Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030

AbstractBackground. This study projected the number of metastatic breast cancer (mBC) cases and costs (medical and productivity) attributable to mBC through 203

Read the full article here

Related Articles